In chronic lymphocytic leukemia, secreted IgM (sIgM) drives tumor progression by inducing the accumulation of myeloid-derived suppressor cells (MDSCs), which inhibit T-cell proliferation and diminish antitumor immune responses (48). This evidence concerns the gene CD40LG and neoplasm.